Works matching IS 01676806 AND DT 2025 AND VI 211 AND IP 3


Results: 21
    1
    2

    Targeting breast cancer: the promise of phage-based nanomedicines.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 211, n. 3, p. 561, doi. 10.1007/s10549-025-07696-5
    By:
    • Gholami, Sarah;
    • Saffarfar, Hossein;
    • Mehraban, Mohammad Reza;
    • Ardabili, Nastaran Safavi;
    • Elhami, Anis;
    • Ebrahimi, Sara;
    • Ali-Khiavi, Payam;
    • Kheradmand, Reza;
    • Fattahpour, Seyedeh Farinaz;
    • Mobed, Ahmad
    Publication type:
    Article
    3
    4

    Comparison of paclitaxel and docetaxel in dual HER2 blockade: efficacy and safety in neoadjuvant treatment of HER2-positive breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 211, n. 3, p. 743, doi. 10.1007/s10549-025-07694-7
    By:
    • Turkoglu, Ezgi;
    • Akdag Topal, Goncagul;
    • Yildirim, Sedat;
    • Kinikoglu, Oguzcan;
    • Sariyar Busery, Nisanur;
    • Aydogan, Miray;
    • Yildiz, Hacer Sahika;
    • Orman, Seval;
    • Bayramgil, Ayberk;
    • Gunes, Tugce Kubra;
    • Tunc, Mustafa Alperen;
    • Majidova, Nargiz;
    • Isik, Deniz;
    • Kokten, Sermin;
    • Odabas, Hatice;
    • Turan, Nedim
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21